ANIX · NASDAQ · Biotechnology

Anixa Biosciences (ANIX)

Develops cancer vaccines and ovarian-cancer CAR-T therapy through institutional collaborations.

$2.75
vs last close−0.04 (−1.43%)
  1. New Strong Buy Stocks for July 22nd

    Zacks Investment Research